Your browser doesn't support javascript.
loading
The benefits of using genetic information to design prevention trials.
Hu, Youna; Li, Li; Ehm, Margaret G; Bing, Nan; Song, Kijoung; Nelson, Matthew R; Talmud, Philippa J; Hingorani, Aroon D; Kumari, Meena; Kivimäki, Mika; Xu, Chun-Fang; Waterworth, Dawn M; Whittaker, John C; Abecasis, Gonçalo R; Spino, Cathie; Kang, Hyun Min.
Affiliation
  • Hu Y; Department of Biostatistics, University of Michigan, Ann Arbor, MI 48109, USA.
Am J Hum Genet ; 92(4): 547-57, 2013 Apr 04.
Article in En | MEDLINE | ID: mdl-23541341
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Research Design / Genetic Variation / Genetic Testing / Diabetes Mellitus, Type 1 / Diabetes Mellitus, Type 2 / Genotype / Macular Degeneration / Myocardial Infarction Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Am J Hum Genet Year: 2013 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Research Design / Genetic Variation / Genetic Testing / Diabetes Mellitus, Type 1 / Diabetes Mellitus, Type 2 / Genotype / Macular Degeneration / Myocardial Infarction Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Am J Hum Genet Year: 2013 Type: Article Affiliation country: United States